Publications
Published information about DBS technology, applications, economic benefits, case studies and more.
Adaptation of Elecsys anti-severe acute respiratory syndrome coronavirus-2 immunoassay to dried blood spots: proof of concept
”Adaptation of Elecsys anti-severe acute respiratory syndrome coronavirus-2 immunoassay to dried blood spots: proof of concept”
Evaluation of the Capitainer-B Microfluidic Device
”Evaluation of the Capitainer-B Microfluidic Device as a New Hematocrit Independent Alternative for Dried Blood Spot Collection”
”Sofie Velghe and Christophe P. Stove”
Cost Evaluation of Dried Blood Spot Home Sampling
”Cost Evaluation of Dried Blood Spot Home Sampling as Compared to Conventional Sampling for Therapeutic Drug Monitoring in Children”;
L. C. Martial , R. E. Aarnoutse, M. F. Schreuder, S. S. Henriet, R. J. M. Brüggemann, M. A. Joore, PLOS ONE, December 12, 2016, e0167433
Study of measurement of the alcohol biomarker
”Study of measurement of the alcohol biomarker phosphatidylethanol (PEth) in dried blood spot (DBS) samples and application of a volumetric DBS device”;
O. Beck, N. Kenan Modéna, S. Seferaj, G. Lenk, A. Helander; Clinica Chimica Acta, 2018; 479 : 38–42.
Clinical perspectives of dried blood spot protein quantification
”Clinical perspectives of dried blood spot protein quantification using mass spectrometry methods”;
S. Lehmann, A. Picas, L. Tiers, J. Vialaret & . Hirtz; Critical Reviews in Clinical Laboratory Sciences, 2017; 54(3) : 173-184
Current and future use of “dried blood spot” analyses in clinical chemistry
”Current and future use of “dried blood spot” analyses in clinical chemistry”;
S. Lehmann, C. Delaby, J. Vialaret, J. Ducos and C. Hirtz; Clin Chem Lab Med 2013 ; 51(10) : 1897–1909
GO TO LINK
Stability of Proteins in Dried Blood Spot Biobanks
”Stability of Proteins in Dried Blood Spot Biobanks”;
J. Björkesten, S. Enroth, Q.Shen, L. Wik, D. M. Hougaard, A.S. Cohen, L. Sörensen, V. Giedraitis, M. Ingelsson, A. Larsson, M. Kamali-Moghaddam, and U. Landegren.; Molecular & Cellular Proteomics, 2017; 16 : 1286-1296.
DBS for Monitoring HIV Viral Load and for Early Infant Diagnosis
”Systematic Review of the Use of Dried Blood Spots for Monitoring HIV Viral Load and for Early Infant Diagnosis”;
P. W. Smit, K. A. Sollis, S. Fiscus, N. Ford, M. Vitoria, S. Essajee, D. Barnett, B. Cheng, S. M. Crowe, T. Denny, A. Landay, W. Stevens, V. Habiyambere, J. H. Perriens, R. W. Peeling. PLOS ONE , 2014; 9(3) : e86461.
NGS on DBS causal mutations in patients with inherited metabolic disease
”A next-generation newborn screening pilot study: NGS on dried blood spots detects causal mutations in patients with inherited metabolic disease”;
F. Boemer, C. Fasquelle, S. d’Otreppe, C. Josse , V. Dideberg, K. Segers, V. Guissard, V. Capraro, FG. Debray and V. Bours; SCIENTIFIC REPORTS, 2017 ; 7: 17641
GO TO LINK
Comparison between dried blood spot and plasma sampling
”Comparison between dried blood spot and plasma sampling for therapeutic drug monitoring of antiepileptic drugs in children with epilepsy: A step towards home sampling”;
C. Linder, K. Wide, M. Walander, O. Beck, LL. Gustafsson, A. Pohanka; Clin Biochem. 2017; 50(7-8) : 418-424.
Potential of Dried Blood Self-Sampling
”Potential of Dried Blood Self-Sampling for Cyclosporine C2 Monitoring in Transplant Outpatients”;
A.B. Leichtle, U. Ceglarek, H. Witzigmann, G. Gäbel, J. Thiery and G. M. Fiedle; J Transplant. 2010; 2010: 201918.
Dried Blood Spot Analysis
”Dried Blood Spot Analysis Suitable for Therapeutic Drug Monitoring of Voriconazole, Fluconazole, and Posaconazole”;
K. C. M. van der Elst, L. F. R. Span, K. van Hateren, K. M. Vermeulen, T. S. van der Werf, B. Greijdanus, J. G. W. Kosterink, D. R. A. Uges, J-W. C. Alffenaar; Antimicrob Agents Chemother. 2013 ; 57(10) : 4999-5004.
Finger Prick Dried Blood Spots for HIV
”Finger Prick Dried Blood Spots for HIV Viral Load Measurement in Field Conditions in Zimbabwe”;
S. N. Mavedzenge, C. Davey, T. Chirenje, P. Mushati, S. Mtetwa, J. Dirawo, B. Mudenge, A. Phillips, F. M.Cowan. PLoS One. 2015 ; 10(5) : e0126878
Therapeutic Drug Monitoring by Dried Blood Spot
”Therapeutic Drug Monitoring by Dried Blood Spot: Progress to Date and Future Directions”;
A. J. Wilhelm, J. C. G. den Burger, and E. L. Swart; Clin Pharmacokinet. 2014 ; 53(11) : 961–973.
Spot them in the spot
”Spot them in the spot: analysis of abused substances using dried blood spots”;
N. Sadones, S. Capiau, P. MM. De Kesel, W. E. Lambert & C. P. Stove; BIOANALYSIS, 2014 ; 6(17)
Dried blood spots from finger prick facilitate
”Dried blood spots from finger prick facilitate therapeutic drug monitoring of adalimumab and anti-adalimumab in patients with inflammatory diseases”;
W.L. Kneepkens , M.F. Pouw , G.J. Wolbink, T. Schaap, M.T. Nurmohamed, A. de Vries, T. Rispens, K. Bloem; Br J Clin Pharmacol. 2017 ; 83(11) : 2474-2484.
Investigation of the effect of blood hematocrit
”Investigation of the effect of blood hematocrit and lipid content on the blood volume deposited by a disposable dried blood spot collection device”;
N. Spooner, A. Olatunji , K. Webbley, J Pharm Biomed Anal. 2018 ; 149 : 419-424
